Anguraj Sadanandam Selected Research

Radiotherapy

1/2021	Differential and longitudinal immune gene patterns associated with reprogrammed microenvironment and viral mimicry in response to neoadjuvant radiotherapy in rectal cancer.
12/2012	Genomic aberrations in normal tissue adjacent to HER2-amplified breast cancers: field cancerization or contaminating tumor cells?
1/2010	The expression level of HJURP has an independent prognostic impact and predicts the sensitivity to radiotherapy in breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anguraj Sadanandam Research Topics

Disease

32	Neoplasms (Cancer) 11/2022 - 01/2007
10	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2007
9	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 05/2013
8	Breast Neoplasms (Breast Cancer) 09/2020 - 07/2008
3	Melanoma (Melanoma, Malignant) 01/2019 - 04/2009
3	Osteolysis 01/2009 - 07/2008
2	Microsatellite Instability 11/2022 - 11/2015
2	Adenocarcinoma 11/2021 - 04/2011
2	Pancreatic Neoplasms (Pancreatic Cancer) 11/2021 - 09/2010
2	Rectal Neoplasms (Rectal Cancer) 01/2021 - 01/2017
1	Cytokine Release Syndrome 12/2020
1	Colonic Neoplasms (Colon Cancer) 01/2020
1	Disease Progression 01/2020
1	Inflammation (Inflammations) 01/2020
1	Ovarian Neoplasms (Ovarian Cancer) 01/2018
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 12/2015
1	Carcinogenesis 12/2014
1	Margins of Excision 12/2012
1	Prostatic Neoplasms (Prostate Cancer) 01/2007

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2010
4	LigandsIBA 09/2021 - 01/2007
4	Pharmaceutical PreparationsIBA 09/2020 - 02/2012
4	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 06/2010
3	Calcibiotic Root Canal SealerIBA 11/2022 - 01/2019
3	Biological ProductsIBA 09/2020 - 01/2017
3	Messenger RNA (mRNA)IBA 12/2015 - 01/2010
2	Phosphotransferases (Kinase)IBA 01/2022 - 01/2009
2	MicroRNAs (MicroRNA)IBA 11/2021 - 12/2015
2	CytokinesIBA 01/2020 - 01/2019
2	ErbB Receptors (EGF Receptor)IBA 01/2020 - 01/2019
2	InterferonsIBA 07/2019 - 01/2019
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 07/2019 - 01/2019
2	Estrogen ReceptorsIBA 01/2019 - 01/2010
2	Semaphorins (Semaphorin)IBA 12/2014 - 09/2010
2	Proteins (Proteins, Gene)FDA Link 09/2010 - 01/2007
2	Small Interfering RNA (siRNA)IBA 01/2010 - 01/2010
2	Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA 01/2009 - 01/2009
2	RANK LigandIBA 01/2009 - 07/2008
2	Cell Adhesion MoleculesIBA 01/2008 - 01/2007
1	Immune Checkpoint InhibitorsIBA 11/2022
1	folfirinoxIBA 11/2021
1	Fluorouracil (Carac)FDA LinkGeneric 11/2021
1	Irinotecan (Camptosar)FDA LinkGeneric 11/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2021
1	CannabinoidsIBA 09/2021
1	Interleukin-6 (Interleukin 6)IBA 12/2020
1	Etoposide (VP 16)FDA LinkGeneric 09/2020
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 09/2020
1	Biological FactorsIBA 01/2020
1	Conditioned Culture MediaIBA 01/2019
1	Phenobarbital (Luminal)FDA Link 01/2019
1	ceralasertibIBA 01/2019
1	Cetuximab (Erbitux)FDA Link 01/2019
1	trametinibIBA 01/2019
1	Antineoplastic Agents (Antineoplastics)IBA 01/2018
1	Complement System Proteins (Complement)IBA 01/2018
1	PlasticsIBA 01/2018
1	Transforming Growth Factors (Transforming Growth Factor)IBA 11/2015
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2010
1	Genetic Markers (Genetic Marker)IBA 12/2009
1	(N(1),N(12))bis(ethyl)- 6,7- dehydrospermineIBA 12/2009
1	PolyaminesIBA 12/2009
1	2- hydroxy- N,N- dimethyl- 3- (2- ((1- (5- methylfuran- 2- yl)propyl)amino)- 3,4- dioxocyclobut- 1- enylamino)benzamideIBA 04/2009
1	2-Hydroxypropyl-beta-cyclodextrinIBA 04/2009
1	SCH 479833IBA 04/2009
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2009
1	Antisense OligonucleotidesIBA 01/2009
1	Transforming Growth Factor-beta Type I ReceptorIBA 01/2009
1	Neutralizing AntibodiesIBA 01/2009
1	Cathepsin GIBA 07/2008
1	Matrix Metalloproteinases (MMPs)IBA 07/2008
1	Peptide Hydrolases (Proteases)FDA Link 07/2008
1	Complementary DNA (cDNA)IBA 07/2008
1	Cathepsin KIBA 07/2008
1	ChemokinesIBA 12/2007
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2007
1	plexinIBA 01/2007
1	Peptides (Polypeptides)IBA 01/2007

Therapy/Procedure

9	Therapeutics 01/2020 - 01/2009
3	Radiotherapy 01/2021 - 01/2010
1	Drug Therapy (Chemotherapy) 11/2021
1	Neoadjuvant Therapy 01/2021
1	Immunotherapy 01/2019
1	Precision Medicine 01/2019
1	Chemoradiotherapy 01/2017
1	Segmental Mastectomy (Lumpectomy) 12/2012